Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.01 is 14% above its 5-year average of 1.77, near the low end of its 5-year range (0.21–6.82).
As of the fiscal period ended Tuesday, June 30, 2026. 8.17% above its 12-month average of 1.86.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.01.
CURRENT RATIO
2.01
CURRENT RATIO AVG TTM
1.86
CURRENT RATIO AVG 3Y
1.13
CURRENT RATIO AVG 5Y
1.77
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+8.17%
CURRENT VS 3Y AVG
+78.02%
CURRENT VS 5Y AVG
+13.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.39
median of 625 covered companies
CURRENT VS SECTOR MEDIAN
-40.70%
vs the sector median at left
Market Cap
$4.43M
Current Ratio
1.57
TTM Avg
3.49
3Y Avg
6.45
5Y Avg
7.07
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | $3.89M | 2.01 | 1.86 | 1.13 | 1.77 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.00M | 2.08 | 2.77 | 2.83 | 2.68 |
| GRI Bio, Inc. (GRI)vs › | $4.13M | 10.30 | 3.34 | 1.98 | 1.38 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.21M | 1.99 | 1.05 | 3.08 | 3.15 |
| Eocene Ltd. (EOCN)vs › | $3.52M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.50M | 1.25 | 6.05 | 6.00 | 4.06 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | 1.57 | 3.49 | 6.45 | 7.07 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 1.97 | 1.45 | 2.21 | 4.94 |
| Moolec Science S.A. (MLEC)vs › | $3.46M | 0.15 | 0.91 | 0.63 | 0.64 |
| Evogene Ltd. (EVGN)vs › | $3.46M | 3.57 | 2.84 | 4.34 | 5.17 |
Current Ratio
2.01
Quick Ratio
2.01
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.01 |
| 2026-03-31 | 2.89 |
| 2025-12-31 | 1.01 |
| 2025-09-30 | 1.58 |
| 2025-06-30 | 1.81 |
| 2025-03-31 | 0.21 |
| 2024-12-31 | 0.80 |
| 2024-09-30 | 0.48 |
| 2024-06-30 | 0.37 |
| 2024-03-31 | 0.79 |
| 2023-12-31 | 1.46 |
| 2023-09-30 | 0.73 |
| 2023-06-30 | 0.54 |
| 2023-03-31 | 1.21 |
| 2022-12-31 | 1.79 |
| 2022-09-30 | 2.12 |
| 2022-06-30 | 3.08 |
| 2022-03-31 | 6.82 |
| 2021-12-31 | 5.10 |
| 2021-09-30 | 5.65 |
| 2021-06-30 | 6.76 |
| 2021-03-31 | 2.23 |
| 2020-12-31 | 0.55 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
